Bromperidol
Thông số
10457-90-6Số CAS
233-943-3Số EC
4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-oneTên IUPAC
C21H23BrFNO2Công thức hóa học
420.3 g/molKhối lượng phân tử
bromperidol; 10457-90-6; Impromen; Bromoperidol; 4-(4-(4-bromophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one; Bromperidolum; DTXSID0022690; 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one; LYH6F7I22E; NSC-759275; R-11333; 4-(4-(p-Bromophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone; 4-(4-(4-Bromophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone; R 11,333; 1-Butanone, 4-(4-(4-bromophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-; DTXCID102690; 1-Butanone, 4-[4-(4-bromophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-; bromperidolo; RefChem:570410; N05AD06; 233-943-3; Azurene; C21H23BrFNO2; 4-[4-(4-Bromophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone; R 11333; 4-(4-(4-Bromophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone; 4-[4-(4-bromophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one; NCGC00016692-01; Tesoprel; CAS-10457-90-6; BUTYROPHENONE, 4-(4-(p-BROMOPHENYL)-4-HYDROXYPIPERIDINO)-4'-FLUORO-; Bromperidolum [INN-Latin]; 4-[4-(p-Bromophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone;4-[4-(p-Bromophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone; SR-05000001811; EINECS 233-943-3; UNII-LYH6F7I22E; CC 2489; BRN 1552256; Bromperidol CRS; Bromperidol; 4-[4-(4-Bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one; Impromen (TN); Bromperidol [USAN:INN:BAN:JAN]; Prestwick_781; MFCD00866670; Bromperidol (Standard); BROMPERIDOL [MI]; 4-(4-(p-Bromophenyl)-4-hydroxypiperidinol)-4'-fluorobutyrophenone; Prestwick0_000509; Prestwick1_000509; Prestwick2_000509; Prestwick3_000509; BROMPERIDOL [INN]; BROMPERIDOL [JAN]; BROMPERIDOL [USAN]; BROMPERIDOL [MART.]; SCHEMBL43755; BROMPERIDOL [WHO-DD]; BSPBio_000437; 5-21-02-00382 (Beilstein Handbook Reference); MLS002153852; CHEMBL28218; SPBio_002358; Bromperidol (JAN/USAN/INN); BPBio1_000481; orb1219157; orb1308514; BDBM81484; CHEBI:31305; HY-B0901R; BROMPERIDOL [EP MONOGRAPH]; HMS1569F19; HMS2093J06; HMS2096F19; HMS2230O05; HMS3370C12; HMS3713F19; Pharmakon1600-01505972; CAS_2448; HY-B0901; MSK11213; NSC_2448; RYB91975; Tox21_110565; EBC-27031; NSC759275; PDSP1_001125; PDSP2_001109; AKOS015914052; Tox21_110565_1; CCG-213579; DB12401; FB19339; NSC 759275; NCGC00016692-02; NCGC00016692-05; NCGC00016692-08; NCGC00179558-01; MS-27369; SMR001233211; SBI-0206864.P001; DB-040551; NS00002733; D01101; F85189; T14830; Bromperidol; Bromperidol Decanoate EP Impurity G; EN300-19767176; F979043; L000662; Q4973749; SR-05000001811-1; SR-05000001811-3; BRD-K78643075-001-03-3; BRD-K78643075-001-06-6; BRD-K78643075-001-11-6; BROMPERIDOL DECANOATE IMPURITY G [EP IMPURITY]; Bromperidol, European Pharmacopoeia (EP) Reference Standard; 4-[4-(p-Bromophenyl)-4-hydroxypiperidino]-4'-fluoro-buty rophenone; 1-Butanone, 4-[4-(4-bromophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-; 4-[4-(4-Bromo-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one; 4-[4-(4-bromophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-oneTên gọi khác